Safe and Standard Thyroid Cancer Surgery, or Lack Thereof: Patterns and Correlates of Patient Referral to Tertiary Care Centre for Revision Thyroid Surgery in a LMIC [0.03%]
安全且规范的甲状腺癌手术，还是缺乏这种手术：LMIC中患者转诊至三级护理中心进行修订甲状腺手术的模式和关联因素
Sunil Malla Bujar Barua,Sanjay Kumar Yadav,Vivek Aggarwal et al.
Sunil Malla Bujar Barua et al.
Saroj Kanta MishraBackground A surgeon's characteristics such as volume and practice setup are essential elements in outcome of thyroid cancer. However, little information is available from the developing world regarding qualities of primar...
The Spectrum of Histomorphological Changes and Pathological Tumor Response following Preoperative Oral Metronomic Chemotherapy in Oral Squamous Cell Carcinoma [0.03%]
口腔鳞状细胞癌术前口服代谢化疗后的组织形态学改变和病理肿瘤反应范围
Sithara Aravind,Jasmin Jose,Praveen Kumar Shenoy et al.
Sithara Aravind et al.
Sithara AravindBackground Oral metronomic chemotherapy (OMCT) represents an emerging concept in cancer treatment involving frequent administration of chemotherapeutic drugs at doses below maximum tolerated doses and with no prolonged drug-f...
Histiocytic Sarcoma of Tibia: A Rare Case Report and Review of Literature [0.03%]
胫骨组织细胞肉瘤：一个罕见病历报告和文献回顾
Ajita Kendre,Bhooshan Zade,Prasant Chandra
Ajita Kendre
Ajita KendreHistiocytic sarcoma is a rare disorder and there has been a lot of confusion and debate regarding its diagnosis and treatment. The World Health Organization (WHO) in 2008 aided in the standardization of diagnosis of histiocytic ...
Prognostic Significance of HE4 Tissue Expression in Serous Epithelial Ovarian Carcinoma [0.03%]
HE4组织表达在浆液性卵巢上皮癌中的预后意义
Ankita Sethi,Lalit Kumar,Sandeep Mathur et al.
Ankita Sethi et al.
Neerja BhatlaBackground Human Epididymis protein 4 (HE4) is expressed in ovarian cancer. Preoperative serum testing is still not widely available. This pilot study aimed to investigate the magnitude of expression of HE4 in tissue sections o...
Audit of In-Hospital Mortality from a Medical Oncology and Hemato-Oncology Center with the Emphasis on Best Supportive Care [0.03%]
肿瘤科及血液肿瘤中心住院死亡率审计-着重于最佳支持性治疗
Deepak Sundriyal,Uttam Kumar Nath,Parmod Kumar et al.
Deepak Sundriyal et al.
Deepak SundriyalBackground and Objectives The newly established medical oncology and hemato-oncology center at the All India Institute of Medical Sciences (AIIMS), Rishikesh, Uttarakhand, India, provided us an opportunity to audit in-hospit...
Retinoblastoma Outcomes in a Tertiary Hospital in Northern Luzon, The Philippines: A 15-Year Experience [0.03%]
菲律宾吕宋岛北部一家三级医院15年视网膜母细胞瘤治疗结果分析
Roland Joseph D Tan,Kathleen Faye B Ballesteros
Roland Joseph D Tan
Roland Joseph D. TanObjective To describe the demographics, clinical profile, and outcomes of retinoblastoma patients seen in a tertiary hospital in northern Luzon. Materials and Methods This is a retrospective cross-sectional study of reti...
Secondary Acute Myeloid Leukemia in a Chronic Myeloid Leukemia Patient in Deep Molecular Response-An Unusual Case Report [0.03%]
处于深度分子响应的慢性髓系白血病患者出现继发急性髓系白血病一例报告
Goranthala Bharathi Devi,Perumal Kalaiyarasi Jayachandran,Jhansi Rani Arumugam et al.
Goranthala Bharathi Devi et al.
Perumal Kalaiyarasi Jayachandran Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder that develops from the stem cell compartment. The classical translocation ( BCR-ABL1 ) is present in approximately 95% of CML patients. ...
Real-World Experience of Treating Young Adult Patients with Breast Cancer from a Single Center in Southern India [0.03%]
来自印度南部一家医疗机构的年轻乳腺癌患者治疗真实世界经验
Priya Iyer,Venkatraman Radhakrishnan,Arvind Krishnamurthy et al.
Priya Iyer et al.
Priya IyerBackground Breast cancer in young adults is rare and accounts for 5 to 6% of all cancers in this age group. We conducted the present study to look at the demographic features, clinical presentation, and outcomes in this group of p...
Real-World Experience with Nivolumab in Metastatic Renal Cell Carcinoma Patients Who Have Progressed on Prior Therapies: A Single-Center Study from India [0.03%]
先前治疗后疾病进展的转移性肾细胞癌患者中nivolumab的真实世界经验：一项印度单中心研究
Amit Rauthan,Nitin Yashas Murthy,Poonam Patil et al.
Amit Rauthan et al.
Amit RauthanIntroduction Nivolumab monotherapy is approved for the treatment of metastatic renal cell carcinoma (mRCC) patients who have progressed on prior therapies based on the pivotal Checkmate-025 trial. There is limited literature on ...
Role of Serum Carcinoembryonic Antigen in Predicting Recurrent Disease following Curative Resection of Rectal Cancer [0.03%]
血清癌胚抗原在预测直肠癌根治术后的复发疾病中的作用
Srikanth Soma,Sachin Gurnule
Srikanth Soma
Srikanth SomaIntroduction Surveillance of patients following definitive treatment of rectal malignancy is based on the predicament that early detection of recurrence may provide an opportunity for cure. Available methods for monitoring incl...